Valuation: Masimo Corporation

Market Cap 9.42B 8.29B 7.81B 7.13B 13.33B 905B 13.44B 93.76B 36.34B 460B 35.38B 34.61B 1,498B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.65B 8.15B 7.44B 13.91B 944B 14.02B 97.81B 37.9B 480B 36.91B 36.11B 1,563B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
6 months+0.85%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 02/08/2026
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 09/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/06/26 Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
23/04/26 Exercice

Director

3,569 0.0068%
23/04/26 Exercice

Director

3,569 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+28.21%+88.61% 9.42B
+0.05%+0.23%+26.00%+29.31% 12.58B
-1.14%+1.80%+15.88%+21.44% 6.76B
+0.27%-6.95% - - 5.78B
+1.92%+2.05%+28.43%+24.55% 5.49B
-3.88%-2.80%-21.58%+34.04% 5.09B
-1.49%+1.77%-29.54%-22.64% 3.97B
+0.18%-2.87%+26.48%-6.34% 1.89B
-0.51%-3.96%-15.65%+184.60% 1.67B
+1.49%0.00%+49.05%-13.19% 1.56B
Average -0.28%-0.44%+11.92%+37.82% 5.42B
Weighted average by Cap. -0.32%-0.27%+15.05%+38.05%

Financials

2024 2025
Net sales 2.09B 1.84B 1.74B 1.58B 2.96B 201B 2.99B 20.84B 8.08B 102B 7.86B 7.69B 333B 1.53B 1.34B 1.27B 1.16B 2.16B 147B 2.18B 15.19B 5.89B 74.6B 5.73B 5.61B 243B
Net income -305M -268M -253M -231M -431M -29.27B -435M -3.03B -1.18B -14.9B -1.14B -1.12B -48.47B -152M -133M -126M -115M -214M -14.54B -216M -1.51B -584M -7.4B -569M -556M -24.09B
Net Debt 668M 588M 554M 506M 946M 64.17B 953M 6.65B 2.58B 32.66B 2.51B 2.46B 106B 407M 358M 337M 308M 576M 39.07B 580M 4.05B 1.57B 19.88B 1.53B 1.49B 64.7B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock